Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Imagenetix, Inc.
NEW YORK, July 19 /PRNewswire-FirstCall/ — Crystal Research Associates, LLC announced today that it has issued an Executive Informational OverviewÃ‚® (EIOÃ‚®) on Imagenetix, Inc. (OTC Bulletin Board: IAGX). The full 52-page report can be found at www.crystalra.com.
Imagenetix, Inc. (“Imagenetix” or “the Company”) develops and markets bioceutical and pharmaceutical products. Bioceuticals, which are estimated to represent a nearly $124 billion industry worldwide, entail bioactive compounds derived from natural based sources that have a beneficial effect on health. Imagenetix’s lead bioceutical product, CeladrinÃ‚®, is designed to lubricate and cushion the joints, promoting comfort and flexibility. Marketed as both a softgel and a topical cream, CeladrinÃ‚® is widely available in the U.S., including at Walgreens, Rite Aid and the world’s largest wholesale club and retail store, among many other retail outlets.
The Company’s bioceutical portfolio further includes a probiotic, BioGuard(TM), for supporting a healthy immune system; a proprietary compound, Trisynex(TM), used in products for fat loss and obesity; and a delivery system, CellSorb(TM), being studied for its effect at increasing the body’s absorption of Coenzyme Q10 (CoQ10). BioGuard(TM) is slated to be sold through all Costco’s and other retail outlets beginning in the fall of this year. Trisynex(TM) is distributed as a bulk raw material. In terms of pharmaceutical development, Imagenetix is conducting preclinical studies of a pilot blend, 1-TDC, and its active compound, MA2009, which may be able to prevent and treat periodontal disease. The majority of the Company’s products are protected by patents.
About Crystal Research Associates, LLC
Crystal Research Associates, LLC is an independent research firm that provides institutional-quality, fee-based research to small- and mid-cap companies. Crystal Research Associates’ unique and novel product, the Executive Informational OverviewÃ‚® (EIOÃ‚®), is free of investment ratings, target prices, and forward-looking financial models. The EIOÃ‚® presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIOÃ‚® details a company’s product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, West Palm Beach, Montreal, and Toronto. Crystal Research Associates has been compensated by the Company in cash of forty thousand dollars and two hundred thousand warrants for its services in creating the base report, for updates, and for printing costs.
Forward-Looking Safe Harbor Statement
Statements in this news release regarding future financial and operating results, potential applications of the Company’s technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements including, limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company’s periodic reports, including forms filed with the SEC.
These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.
Contact: Jeffrey J. Kraws/Karen B. Goldfarb Crystal Research Associates, LLC P: (609) 306-2274, F: (609) 395-9339
SOURCE Imagenetix, Inc.